Dr Demetre Daskalakis

Dr Demetre Daskalakis is the Director of the Division of HIV/AIDS Prevention, Centres of Disease Control and Prevention (CDC), United States of America.

Dr. Daskalakis  was integral in designing and leading many HIV and STD programs in New York City, including their Ending the Epidemic program, which is credited with decreasing HIV incidence to an historic low.

Dr. Daskalakis began his career as an attending physician at Bellevue Hospital in New York City, where he spearheaded several public health programs focused on community HIV testing and prevention. He has since served in a number of capacities in both healthcare and public health in New York City. Most recently, he served as the Deputy Commissioner for the Division of Disease Control at the New York City Department of Health and Mental Hygiene. 

Dr. Daskalakis directed the public health laboratory and all infectious disease control programs for New York City, including HIV, tuberculosis, sexually transmitted infections, vaccine-preventable diseases, and general communicable diseases.  In addition to his leadership in daily infectious disease control efforts, he has served as the New York City Department of Health and Mental Hygiene incident commander during the measles outbreak of 2018-2019, as well as the current COVID-19 public health emergency since January 2020.

Dr. Daskalakis received his medical education from the New York University School of Medicine and completed his residency training at Beth Israel Deaconess Medical Center in Boston. He also completed clinical infectious disease fellowships at the Brigham and Women’s Massachusetts General Hospital combined program and received a Master of Public Health from the Harvard T.H. Chan School of Public Health. He has authored or co-authored more than 50 scholarly articles and has received numerous awards for his scientific and public health contributions, including the Treatment Action Group Research in Action Award, the Latino Commission on AIDS Esperanza Award, the GMHC Hector Xtravagnza Xcellence Award, and the World AIDS Day awards from both New York City and New York State. He has also been recognized as a prominent voice for the LGBTQIA+ community by the New York Times, City and State, Out magazine, Metrosource, and Paper magazine.

Dr. Daskalakis is recognized nationally and internationally as an expert in HIV prevention and has focused much of his career on the treatment and prevention of HIV and other STIs as an activist physician with a focus on LGBTQIA+ communities. He has also dedicated much of his time to improving the health of underserved communities and is passionate about addressing health equity. W

Dr. Daskalakis is deeply committed to addressing stigma in HIV by promoting “status neutral” service delivery and programming and by improving overall health and wellbeing of people with or at risk for HIV by addressing key social determinants of health. He has also shown tremendous dedication to ensuring that biomedical prevention options, like PrEP, are accessible and affordable to all who can benefit from them and that the importance of viral suppression as prevention is recognized by public health, healthcare, and the community at-large.